Involvement of reduced acetylcholine release in Δ9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze

被引:44
作者
Mishima, K
Egashira, N
Matsumoto, Y
Iwasaki, K
Fujiwara, M [1 ]
机构
[1] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Fukuoka 8140180, Japan
[2] Kyushu Womens Jr Coll, Dept Sch Nursing, Kitakyushu, Fukuoka 8078586, Japan
关键词
Delta(9)-tetrahydrocannabinol; spatial memory; 8-arm radial maze; acetylcholine release;
D O I
10.1016/S0024-3205(02)02274-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To clarify the mechanism by which Delta(9)-tetrahydrocannabinol, a major psychoactive component of marijuana, impairs spatial memory in the 8-arm radial maze in rats via the cholinergic system, we used two acetylcholinesterase inhibitors, physostigmine and tetrahydroaminoacridine. Moreover, we examined the effect of Delta(9)-tetrahydrocannabinol on acetylcholine release in the frontal cortex and dorsal and ventral hippocampus using in vivo microdialysis. Physostigmine (0.01-0.05 mg/kg, i.p.) and tetrahydroaminoacridine (1-5 mg/kg, p.o.) improved the impairment of spatial memory induced by Delta(9)-tetrahydrocannabinol (6 mg/kg, i.p.) in the 8-arm radial maze. Delta(9)-tetrahydrocannabinol (6 mg/kg, i.p.) produced a significant decrease in acetylcholine release in the dorsal hippocampus as assessed by microdialysis. Moreover, tetrahydroaminoacridine at a dose of I mg/kg, which improved the impairment of spatial memory, reversed the decrease in acetylcholine release induced by Delta(9)-tetrahydrocannabinol in the dorsal hippocampus during 60-120 min after the Delta(9)-tetrahydrocannabinol injection. These findings suggest that inhibition of the cholinergic pathway by reduced acetylcholine release is one of the means by which Delta(9)-tetrahydrocannabinol impairs spatial memory in the 8-arm radial maze. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:397 / 407
页数:11
相关论文
共 29 条
[1]   Δ9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo:: a microdialysis study [J].
Acquas, E ;
Pisanu, A ;
Marrocu, P ;
Goldberg, SR ;
Di Chiara, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 419 (2-3) :155-161
[2]   Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo [J].
Acquas, E ;
Pisanu, A ;
Marrocu, P ;
Di Chiara, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (02) :179-185
[3]   Inhibition of hippocampal acetylcholine release after acute and repeated Δ9-tetrahydrocannabinol in rats [J].
Carta, G ;
Nava, F ;
Gessa, GL .
BRAIN RESEARCH, 1998, 809 (01) :1-4
[4]  
CLARK L D, 1970, Archives of General Psychiatry, V23, P193
[5]   MARIJUANA, MEMORY, AND PERCEPTION [J].
DORNBUSH, RL ;
FINK, M ;
FREEDMAN, AM .
AMERICAN JOURNAL OF PSYCHIATRY, 1971, 128 (02) :194-&
[6]   Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A [J].
Gessa, GL ;
Casu, MA ;
Carta, G ;
Mascia, MS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 355 (2-3) :119-124
[7]   Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes [J].
Gifford, AN ;
Bruneus, M ;
Gatley, SJ ;
Volkow, ND .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (03) :645-650
[8]   Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices [J].
Gifford, AN ;
Samiian, L ;
Gatley, SJ ;
Ashby, CR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 324 (2-3) :187-192
[9]  
Gifford AN, 1996, J PHARMACOL EXP THER, V277, P1431
[10]   A performance-dependent adjustment of the retention interval in a delayed non-matching-to-position paradigm differentiates effects of amnestic drugs in rats [J].
Han, CJ ;
Pierre-Louis, J ;
Scheff, A ;
Robinson, JK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 403 (1-2) :87-93